Navigation Links
Consumer Watchdog Warns HMO Regulator Not to Side With Insurers Over Illegal Coverage Cancellations
Date:5/14/2008

Big 5 Health Insurers Named In Cancellation Lawsuits Contributed $804,600 to Governor

SANTA MONICA, Calif., May 14 /PRNewswire-USNewswire/ -- Consumer Watchdog today said that according to industry insiders the state's top HMO regulator is considering a deal with Kaiser that would allow the company to avoid paying for past medical bills for some patients whose coverage was illegally cancelled when they got sick. The deal is also rumored to include provisions designed to limit Kaiser's legal liability.

After two years of high-profile media coverage of widespread coverage cancellations, the Department of Managed Health Care (DMHC) recently announced plans to require insurers to reinstate coverage, though no formal orders for reinstatement have yet been issued.

Download the letter at: http://www.ConsumerWatchdog.org/resources/KaiserSettlementLetter.pdf

In the letter, Consumer Watchdog wrote:

"We have heard disturbing rumors that the Department will soon announce a settlement with Kaiser regarding illegal retroactive cancellations of coverage that falls significantly short of your duty to protect patients by allowing Kaiser to continue to refuse to pay past medical bills. What's worse, we understand that the agreement is also aimed at limiting Kaiser's future legal liability to patients who were left uninsured when they got sick and needed coverage the most -- some of whom have lost their jobs and their homes because of Kaiser's malfeasance...

"[A]ll previous rescissions carried out without a showing of willful misrepresentation were premature at best, and therefore wrongful, and patients must be immediately put back in the position that they were in prior to losing coverage. Dragging patients through months of review before reinstatement and/or full payment of past medical bills is simply further unjust punishment.

"Yo
'/>"/>

SOURCE Consumer Watchdog
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. LIFE Foundation Launches Lifehappens.org to Help Consumers Make Smart Insurance-Buying Decisions
2. Blue Cross and Blue Shield of Illinois Names New Vice President, Local and Consumer Markets
3. Smart Balance to Webcast Presentation at Goldman Sachs Consumer Products Symposium
4. Nations First of its Kind Consumer Medication Return Initiative Creates Momentum for Safe Drug Disposal in the U.S.
5. A Statement from GlaxoSmithKline Consumer Healthcare on 2008 Update to the U.S. Public Health Service Guideline on Treating Tobacco Use and Dependence
6. Consumer Reports: Some Drug Prices Can Vary By $100 or More for the Same Bottle of Pills
7. State House Passes Bill to Help Consumers Struggling With High Summer Electric Bills
8. Whats Natural When it Comes to Personal Care Products? Consumers Finally Get Help with New Seal and Standard From the Natural Products Association
9. Consumers, Businesses, Unions, and Medical Professionals: Time for Congress to Act on E-Prescribing Legislation
10. Engaging Health Care Consumers Online is Top Priority
11. The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)... Articles on Breast Cancer and Shopping,Offers Ben...t. 7 /PRNewswire-FirstCall/ -- BOOMj, Inc. (OTC,Bu...ading social networking,community for Baby Boomers... commitment to supporting all those touched by bre...in/prnh/20070131/BOOMJLOGO ), Every day in Octob...
(Date:10/7/2008)... More Than 20 Pink Products All,Year Long With a P...r the,Cure(R) at HelpHopeBloom.com, SAN DIEGO, Oc...,awareness and help the fight against breast cance...he Cure Pink Ribbon Collection. Launched in 2001,...year-round and includes,Pink Ribbon Tulips, the Pi...
(Date:10/7/2008)...-- Viant, Inc. today announced,that the company ha...caid,Services (CMS) that it was not selected to se... rollout of the Medicare Recovery Auditing,Contrac...t contracts were,awarded in the four RAC regions t... CMS,s minimum technical requirements, with no sin...
(Date:10/7/2008)...3OOO Group, Inc. (MED3OOO), a,national leader in h...ervices for providers and employers, recently appo...liance and Ethics Officer. Ms. Hoffman has 29,year...10 years in,healthcare compliance and risk managem...le for the oversight of,MED3OOO,s corporate compli...
Breaking Medicine News(10 mins):Health News:BOOMj, Inc. Joins Fight Against Breast Cancer 2Health News:BOOMj, Inc. Joins Fight Against Breast Cancer 3Health News:Breast Cancer Awareness Blooms in October With ProFlowers 2Health News:Breast Cancer Awareness Blooms in October With ProFlowers 3Health News:MED3OOO Appoints Angela Hoffman as Chief Compliance Officer 2
...ew study shows that infants born under 5.5 pounds ...k for developing // type 2 diabetes later in life....trition isn't the only cause of prenatal malnouris...nta and its blood vessels and high blood pressure,...
...ording to a recent study researchers say, Monteluk...es mediate inflammation // in the body and play a ...f asthma in young children by about 32 percent whi...searchers conducted a one-year study involving 549...
... had urged the people to be prepared for any outbr...Although the //disease mainly spreads from birds t...ptical that the strain of virus that causes bird f...ad the disease human to human, and cause an influe...
...tiapine, a drug used to treat agitation in patient...n cognitive decline say researchers based on findi...g home patients were observed . Twenty-six of the ...chotic also known as Seroquel), 25 received rivast...
Other Medicine News:
(Date:10/6/2008)...or to the understanding of and possible t..., BILLERICA, Mass., Oct. 6 /- Seahor...irst ever analytical instrument for the,kinetic me...cytoplasmic,glycolysis in cells in a 96 well micro...ellular bioenergetics have been relatively unchang...
(Date:10/6/2008)...s with Durezol Dosed Prior to Surgery, TAMPA, Fla...., a,privately held ophthalmic-focused biopharmace...difluprednate ophthalmic emulsion) 0.05% is now,co...by the U.S. Food and,Drug Administration in June 2...ted for the treatment of inflammation and pain ass...
(Date:10/6/2008)...heduled for 9:00 AM ET Today -, SEATTLE, Oct. 6 /...daq:,DNDN) announced today that it has completed t...ized, double-blind, placebo-controlled IMPACT,(IMm...also known as D9902B),clinical trial designed to a...al active cellular immunotherapy PROVENGE(R) (sipu...
(Date:10/6/2008)...inking polyphenol-rich 100% Concord grape,juice wa...intake or body,weight, CONCORD, Mass., Oct. 6 /PR...l-rich Concord grape juice did not cause significa... appetite and was shown to reduce waist,circumfere...nual Meeting of,the American College of Nutrition ...
Breaking Medicine Technology:Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 2Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 1943 1China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 1943 2China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 1943 3China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 1943 4Signalife Receives FDA Clearance for OTC Non Prescription Event Recorder Device 1941 1Signalife Receives FDA Clearance for OTC Non Prescription Event Recorder Device 1941 2Signalife Receives FDA Clearance for OTC Non Prescription Event Recorder Device 1941 3Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Piper Jaffray Conference 1939 1Bio advancements Expected to Drive Burn Care Market Growth Up 24700 Million 1937 1Bio advancements Expected to Drive Burn Care Market Growth Up 24700 Million 1937 2
...IRE) -- July 02, 2007 -- DOR BioPharma, Inc.,(OTCB...that the,first results from testing of a multivale...ade;, have been published in the journal,Infection...n and,Immunity, v. 75, p. 3043 ). These results ar...elicited by a multivalent vaccine,that is active b...
...o Timeline for Second Pivotal Phase 3 Trial CL-05,...Advanced Life,Sciences Holdings, Inc. , today anno...ta from Trial CL-06, the first of two,pivotal Phas...and,effectiveness of cethromycin, a novel once-a-d...ired pneumonia (CAP). The Company,also provided an...
Other Medicine Technology:DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 2Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 3Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 4Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 5Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 7
New Image Drainable Pouch, Ultra-Clear without Filter
New Image Drainable Mini-Pouch, Beige
New Image Cut-to-Fit Flextend Skin Barrier, Floating Flange, with Tape
New Image Cut-to-Fit Convex Flextend Skin Barrier, with Tape
Medicine Products: